MikesLM, thank you the response. I read the Veritas report, which as you say is now mostly old news.
As you point out the Petra report is no longer up, perhaps the company will grant access directly.
Looking positive for the short to medium term especially with Remplir approvals pending in Asia and USA.
One query I have is around the portability of OrthoATI/ACI treatment outside Australia, given the need for a dedicated Lab. How much capital would be required to set up operations overseas. Might the company look to strike licence deals of some sort.
MikesLM, thank you the response. I read the Veritas report,...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.010(2.63%) |
Mkt cap ! $78.49M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 37.5¢ | $64.05K | 168.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90080 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 47873 | 3 |
View Market Depth
| Last trade - 15.42pm 08/08/2024 (20 minute delay) ? |
| OCC (ASX) Chart |